Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: vaccines - Cytos Biotechnology

Drug Profile

Research programme: vaccines - Cytos Biotechnology

Alternative Names: C5aQb; CCR5Qb; CYT015-M2AP; CYT017-IL17Qb; DENAP; IL17Qb; IL1aQb; IL5Qb; IL6Qb; MIFQb

Latest Information Update: 13 May 2014

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cytos Biotechnology
  • Class Virus-like particle vaccines
  • Mechanism of Action Cytokine modulators; Immunomodulators; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Suspended Inflammation; Multiple sclerosis; Psoriasis
  • No development reported Dengue; HIV infections
  • Discontinued Atherosclerosis; Cancer; Creutzfeldt-Jakob disease; Hepatitis B; Hypersensitivity; Osteoporosis; Systemic lupus erythematosus

Most Recent Events

  • 13 May 2014 Research programme: vaccines - Cytos Biotechnology is available for licensing as of 05 May 2014. http://www.cytos.com
  • 18 Aug 2011 Suspended - Preclinical for Inflammation in Switzerland (unspecified route)
  • 18 Aug 2011 Suspended - Preclinical for Multiple sclerosis in Switzerland (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top